Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Ultragenyx Pharmaceutical Inc. buy HC Wainwright

Start price
€40.20
14.02.25 / 50%
Target price
€90.54
14.02.26
Performance (%)
-27.36%
Price
€29.20
23.12.25
Summary
This prediction is currently active. The prediction for Ultragenyx Pharmaceutical Inc. disappoints with a performance of -27.36%. This prediction currently runs until 14.02.26. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Ultragenyx Pharmaceutical Inc. 0.000% 0.000%
iShares Core DAX® 0.323% 2.208%
iShares Nasdaq 100 0.145% -0.987%
iShares Nikkei 225® 0.091% -1.421%
iShares S&P 500 0.371% -0.469%

Comments by HC_Wainwright for this prediction

In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -27.36%
Target price 90.545
Change
Ends at 14.02.26

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $95.00 price target on the stock.
Ratings data for RARE provided by MarketBeat

Stopped prediction by HC_Wainwright for Ultragenyx Pharmaceutical Inc.

buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€27.00
09.09.25
€67.95
09.09.26
-37.78%
23.12.25

buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€23.80
28.07.25
€68.10
28.07.26
-29.41%
23.12.25

buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€42.00
24.12.24
€91.30
24.12.25
-60.71%
25.12.25

buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€48.20
06.11.24
€88.68
06.11.25
-44.40%
07.11.25

buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€38.80
01.08.23
€74.73
01.08.24
3.09%
02.08.24